PCI Biotech and MDimune Inc. announced a preclinical research collaboration that would offer several opportunities for future development.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.878 NOK | +1.51% |
|
-1.16% | -10.36% |
1st Jan change | Capi. | |
---|---|---|
-10.36% | 6.47M | |
+15.20% | 122B | |
+19.67% | 113B | |
+18.95% | 26.49B | |
-23.86% | 19.4B | |
-19.03% | 16.24B | |
-20.90% | 15.4B | |
-46.14% | 15.15B | |
+63.85% | 14.93B | |
+4.49% | 13.52B |
- Stock Market
- Equities
- PCIB Stock
- News PCI Biotech Holding ASA
- PCI Biotech and MDimune Announce Research Collaboration Agreement